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Abstract. 
Background: The deep inspiration breath hold technique (DIBH) is widely used for left- sided breast radiotherapy 
(RT), in order to reduce the dose to the heart and the risk of cardiotoxicity. The volumetric arc therapy (VMAT) 
technique increases the dose conformity to the planning target volume (PTV). We hereby describe the procedure of 
combining VMAT and DIBH without a dedicated equipment, and report a dosimetric study related on our 
implemented VMAT-DIBH technique.  
Methods: The DIBH technique is based on voluntary breath hold of the patient which is controlled by a laser on 
tattoo marks. Patients were selected depending their ability to breath hold for 25s, and VMAT plans were optimized 
with an arrangement of 4 arcs with a maximum delivery time of 20s each. A retrospective dosimetric study was 
undertaken on 30 patients treated with this technique: 10 of them received local (whole breast) RT (L-RT) with a 
simultaneous integrated boost (SIB), 10 had locoregional (LR) RT (supraclavicular, axillary, internal mammary chain 
regions) of the chestwall, and 10 received a LR RT of the whole breast with SIB. For these patients, their DIBH-VMAT 
treatment plans were compared to free breathing (FB) VMAT plans (with their same respective treatment volumes), 
and dose characteristics of PTV and organs at risk (OAR) were evaluated. 
Results: The PTV coverage was identical among plans under DIBH or FB: 95% of the volume covered by 95% of the 
prescribed dose. The mean heart dose was reduced from 2.8±0.9Gy in FB to 1.8±0.6Gy in DIBH (p<0.006) for local RT, 
and reduced from 3.4±1.3Gy in FB to 2.2±0.5Gy in DIBH (p<0.004) for LR-RT. The ipsilateral mean lung dose was 
reduced by a factor of 12% (p<0.009) for LR-RT, but remained unchanged for L-RT with DIBH-VMAT compared to FB 
treatment. No significant differences were observed in the mean dose of contra-lateral organs with either DIBH or FB 
VMAT techniques.   
Conclusion: The VMAT-DIBH technique performed without a dedicated breath hold equipment, provided important 
dose reductions at the heart, while preserving the ipsilateral lung and contralateral normal tissues. VMAT-DIBH 
might represent a clinically relevant method to reduce dose to the heart and ipsilateral lung during left breast RT. 
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Introduction 
Adjuvant radiotherapy (RT) plays a central role in the curative setting of breast cancer (BC) treatment [1-6]. 
However, RT especially when associated with systemic treatments (trastuzumab, anthracyclines, taxanes) can be 
associated with several long term risks of cardiotoxicity [7]. It has recently been shown that every Gy delivered to 
the heart is associated with a 7% increase of coronary events [8]. Therefore, the benefit of RT should be weighted 
against the risk of late toxicity, and methods to decrease the dose delivered to the heart are clinically relevant. 
3D conformal radiotherapy (3DCRT) with tangential beams is regularly used for breast cancer treatment. New 
technologies, such as Volumetric Arc Therapy (VMAT) or Tomotherapy, allow the delivery of a precise "sculpted" and 
less heterogeneous dose to concave planning target volumes (PTV) [9]. VMAT is an emerging suitable technique for 
breast irradiation, allowing optimal dose sparing of surrounding organs at risks (OAR), such as the lung and heart, 
and being competitive with 3DCRT to avoid the contralateral breast [10-12].  
The deep inspiration breath hold (DIBH) technique is well known to reduce doses delivered to the heart, by 
increasing the distance between the heart and the breast [13-18]. The combination of VMAT with DIBH is increasing 
and performed with commercially available respiration monitoring devices. The two main gated respiratory systems 
(GRS) used for DIBH treatments, are Real time Position Management (RPM) from Varian and the Active Breathing 
Coordinator (ABC) from Elekta  [19-21], while several other respiratory monitoring systems (commercially available 
or not) are under development [22-25].However, these systems are costly and might not be widely available.  
We hereby describe a low-cost technique of associated DIBH-VMAT delivered without a dedicated equipment. The 
method is based on voluntary breath hold of the patient which is checked by a laser on the tattoo marks throughout 
the treatment. This technique has already been used in other facilities, but the DIBH was combined with 3DCRT [26-
27]. A multi disciplinary working group of physicians, physicists and radiation therapists (RTT), elaborated a detailed 
procedure before the implementation of this technique. All physicians, physicists and RTTs involved in the treatment 
delivery, underwent a dedicated training to the predefine procedure, before applying this method to patients. 
Between 2016-2018, we have treated 451 breast cancer patients with VMAT in our institution, 183 of whom with the 
VMAT-DIBH technique described in this publication. 
In this manuscript, we describe the implementation of VMAT-DIBH, we report a dosimetric study on 30 of the above 
mentioned patients comparing DIBH-VMAT with free breathing (FB) VMAT (for the same patients and treatment 
volumes), and discuss the advantages and pitfalls of this technique. 
 
Materials / Methods 
A-  Procedure. 
Computed Tomography (CT) simulation 
Given that no dedicated equipment was used for respiratory monitoring, the DIBH was actively monitored by the 
radiation therapist throughout the whole procedure. The RTT instructed the patient to breath-hold and then 
checked the positioning by using as reference the vertical laser. During the first breath hold, the RTT made a 
temporary mark, as a reference to determine whether the DIBH was reliable. For each DIBH, the laser should match 
this mark within a ± 3mm limit.  
Before the CT simulation the RTT checked: 
- The ability of the patient to hold one's breath for more than 25s, using a manual timer.  
- The accuracy and the reproducibility of the DIBH position during the breath hold (marks on the patient).  
- The ability of the patient to breath hold appropriately at least 3 consecutive times. 
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A first CT scan (Philips Brillance CT 64) was performed in free breathing to determine the isocenter, which was 
marked on the patient's skin. Radio-opaque CT markers were then placed on this isocenter. Subsequently, a second 
scan was performed in breath hold position, with CT opaque markers in place, in order to determine the exact 
position of the isocenter in DIBH. Throughout the CT scan, the RTT actively checked, by observing the inspiration 
movement of the patient, that the breath hold was adequate. The two image sets (FB and DIBH) were compared 
after a rigid registration on Velocity (Varian). After evaluation of the distance from the heart to the thoracic wall in 
both CT scans, the decision to use the DIBH CT scan is taken by the physician. 
Treatment planning and quality Assurance 
Treatment plans, generated with the treatment planning system (TPS) Philips Pinnacle 14, were optimized with four 
6MV photons partial arcs set as follow: first arc: from 135 to 90 ± 5 degrees CCW, second arc: from 90 to 135 ± 5 
degrees CW, third arc: from 300 to 350 ± 5 degrees CW and fourth arc: from 350 to 300 ± 5 degrees CCW, in order to 
optimize the global treatment time. In case of a DIBH plan, a maximum duration of 13s for each single arc is 
introduced in the TPS Pinnacle.  
The quality assurance (QA) of VMAT plans was performed by the Octavius 4D phantom (PTW Freiburg), with an 
absolute dose measurement. The plan acceptance was based on the gamma index pass-fail test, with the following 
criteria:  95% of the points had to reach the prescribed dose within a tolerance of 3%-3mm. In the process of 
implementation of the DIBH technique, the beam was voluntary interrupted during delivery for the first 10 patients 
QA, in order to check if there is any influence on the gamma index test. 
Treatment delivery 
Patient positioning was undertaken in DIBH conditions. As the gantry moved during the VMAT rotation and might 
hide the laser, it is necessary to use two video cameras with a good focus, in order to ensure continuous monitoring 
of the patient breath hold. The first camera placed on the left side of the patient, was used as the reference for the 
treatment position. The second one, placed at the right side, monitored the patient DIBH while the gantry hided the 
laser on the left side. The control of longitudinal, lateral and vertical lasers was performed every day (morning 
checks QA) and should remain within a tolerance of ± 2mm. 
All treatments were performed on Elekta Agility 160 following the procedure described below: 
For every patient treated in DIBH mode, an alert message in the treatment window of our record&verify Elekta-
Mosaiq had to be approved by the treating RTT. Positioning lasers were then switched on at the beginning of the 
procedure. The control timer of the laser has been set for 30min which is greater than the time needed for the 
whole treatment. A cone beam CT (CBCT-XVI) in DIBH was performed to control the positioning of the patient before 
each treatment session. A fast CBCT protocol has been developed, providing an image in two acquisitions, needing 
only two breath holds of maximum 20s. After having applied the registration and corrections, the treatment was 
delivered for the 4 arcs. A radiation therapist asked the patient to breath hold and delivered the treatment when 
marks on the patient correspond to those set on the laser beams within a threshold of ±3mm (Figure 1). During the 
delivery, the RTT, trained for this technique, continuously checked if the laser remained on the skin marks. If during 
the treatment the patient's position moved out of these limits, the RTT immediately switched off the beam. All the 
registrations and corrections applied were saved in Mosaiq and for the first 30 patients, videos of the treatment 
were also recorded for the staff training. During the implementation phase of the technique, a properly trained 
physician and physicist were also present during the CBCT and treatment delivery. 
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Figure 1: Two video cameras (left &right) to check the breath hold of the patient with marks and margins of 
±3mm. 
 
B- Dosimetric evaluation 
Patients  
Treatment plans of 30 patients receiving adjuvant radiotherapy for non-metastatic breast cancer with the VMAT-
DIBH technique were retrospectively included in this dosimetric study. Additional (non-delivered) treatment plans 
were calculated on the same patients and treatment volumes with FB-VMAT. The paired plans were compared for 
every patient.  
The whole cohort was composed of 3 groups: 
- 10 patients who received a local (L)-irradiation after BC surgery, with target volumes consisting of the whole 
left breast (50Gy; 2Gy/ fraction) with a simultaneous integrated boost (SIB) to the tumor bed (60Gy; 2.4Gy/fraction): 
group L-RT  
- 10 patients who received a locoregional (LR)-irradiation after mastectomy, with target volumes consisting of 
the supraclavicular area (SCLV), the upper axilla (AX), the Internal mammary chain (IMC) (50Gy; 2Gy fraction) and the 
chest-wall (50Gy; 2Gy fraction) : group LR-RT ChestW 
- 10 patients who received a LR-irradiation after BC surgery, with target volumes consisting of the whole 
breast, the SCLV and  the IMC (50Gy; 2Gy fraction) with a SIB to the tumor bed: group LR-RT SIB.  
Dosimetric evaluation 
The delineation of the PTV and OAR's were performed on both scans (FB and DIBH) by the same referring physician, 
using the Radiation Therapy Oncology Group (RTOG) and European Society of Therapeutic Radiology (ESTRO) atlas 
[28,29]. For breast treatments with VMAT, it is strongly recommended to delineate the contralateral breast and lung, 
in order to evaluate low doses derived from beam delivery. In order to provide an accurate comparison, arc 
arrangement was exactly the same in FB than in DIBH, except for the delivery duration which could be increased up 
to 100s given that no breath hold was performed. The dose prescription, according to institutional margins, was on 
an extended PTV, with a margin of 5mm, to still ensure adequate PTV coverage in case of eventual misalignments. 
(figure 2). A virtual bolus of 1cm is systematically added to the breast for VMAT calculation in the TPS in order to 
simulate a bigger PTV in case of breast swell during the treatment as well as the breathing movement during FB plan 
delivery as properly described [30]. 
The dose volume histograms (DVH) of the DIBH-VMAT plans were compared to FB-VMAT plans. The plans were 
classified within 3 categories, corresponding to the clinical cohorts: L-RT, LR-RT-ChestW, LR-RT-SIB. A different set of 
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normal tissue constraints was used for each context based on institutional target and normal tissue constraints 
(Table 1). For each patient the lung volume has been measured in Pinnacle for FB and DIBH. 
 
 
Figure 2. PTV extended and virtual bolus. 
 
Structure Constraints 
L-RT LR- RT
PTV D95% >95% D95% >95% 
Dmax 115-120% Dmax 115-120%
Contra lateral Breast 
V3<5% 
V3<5%
Dmean< 2 (3) Gy Dmean< 2 (3) Gy
Heart V40 =0 V40<5%
V20(25)<5%; V20<10%
V10<30% V10<30%
Dmean <4Gy Dmean <4Gy
Ipsilateral lung V20<25%; V20<35%
V10<35-40% V10<35-40%
V5<50% V5<50%
Dmean<10Gy Dmean<10Gy
contralateral lung V5<10-15% V5<10-15%  
Table 1: Institutional constraints of PTV and OARs for Local RT and Locoregional RT 
 
Results 
 
A- Procedure 
The average of longitudinal, lateral, and vertical displacements needed after the CBCT image registration during the 
treatment for the 30 patients studied, are summarized in the table 3. These values remain within the limits of our 
extended PTV throughout the whole treatment for any of the given patients, maintaining an adequate PTV coverage.  
All QA measurements respected the gamma index criteria with an average of 97.0±1.3% points within the tolerance 
of 3%-3mm. The interruption of the beam was tested during QA measurements of the first 10 treatments.  At the 
moment the 'stop button' was activated, the beam was immediately switched off (response time <0.5s). No 
influence was seen on the QA procedure, by stopping the beam during the dose delivery.  
1 cm Vitual bolus Extended PTV 
+ 5mm 
PTV 
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During the QA procedure, the delivery time of each arc was measured with a manual timer. No discrepancy between 
the planned and the delivered time was noticed. A latency period of 4.0±0.5s, between the time when the 'Start' 
button is pressed until the exact moment the beam is turned on, has to be taken into account, which increased the 
total delivery time to 20.0±2s and 22.0±3s for L and LR irradiation, respectively. 
No major difficulty for the patients to perform the breath hold procedure for 25s was observed. All of the treatments 
were successfully delivered, with no need to transform a DIBH treatment to a FB one. 
 
B- Dosimetric evaluation  
The dosimetry data for the PTV and OAR by each group and by technique are summarized in Table 2.  
The PTV coverage was the same for both FB and DIBH techniques for all groups and no significant differences were 
observed for the maximum dose. Doses received by OARs with FB-VMAT and DIBH-VMAT were compared and are 
highlighted in the mean DHVs by patient group (Figure 3).  
An important reduction in the dose delivered to the heart with the DIBH-VMAT technique was achieved. The mean 
heart dose, the V10Gy and V20Gy were statistically significantly lower by DIBH compared to FB. The mean heart 
dose decreased by a factor of 40% by DIBH compared to FB (p<0.005), with a value of 1.8±0.6Gy and 2.2±0.8Gy for L-
RT and LR-RT respectively. The DIBH-VMAT technique reduced the ipsilateral lung mean dose by a factor of 12% 
(p<0.009) for LR-RT, but remained unchanged for L-RT with DIBH-VMAT compared to FB treatment. During DIBH, the 
lung volume expand by a factor of 57% (mean volume 1241 ± 340 cc in FB  and 2152 ± 409 cc in DIBH)  which might 
explain the mean lung dose reduction.  Contra-lateral OARs (lung and breast) did not show any statistically significant 
difference in terms of dose received by either technique (p>0.2) 
As no delivery time limitation was introduced to optimize FB-VMAT plans, the average delivery time given by the TPS 
was : 31±15s/arc, 36±11s/arc and 46±12s/arc for L-RT, LR-RTchestW, LR-RT SIB respectively. This delivery time was 
reduced in DIBH to: 16±2s/arc and 18±3s/arc for L-RT and LR-RT (ChestW or SIB) respectively, given the introduced 
constraint of delivery time / arc (<20s). Due to a larger target volume to treat, the time per arc slightly increased for 
LR-RT and correlated to the number of delivered monitor units (MU) (Figure 4). 
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Table 2: Summary of dosimetry data for the PTV and OARs by FB-VMAT and DIBH-VMAT technique for L-RT, LR-
RTChestW, LR-RT SIB groups and their respective standard deviations. 
 
Structure Parameters VMAT-DIBH
L-RT
VMAT-FB
L-RT
Difference p_value
PTV D95%(%) 96.8±1.4 96.9±1.8 0% 0.60436
Dmax/Dprescr (%) 104.4±1.2 103.4±0.9 1% 0.06335
Contra lateral Breast Dmean(Gy) 0.9±0.2 0.9±0.3 0% 0.73530
Heart V40Gy(%) <0.1 <0.2 - 0.34344
V20Gy(%) <0.4 1.3±1.0 -147% 0.03179
V10Gy(%) <0.7 3.1±2.7 -144% 0.02120
Dmean(Gy) 1.8±0.6 2.8±0.9 -43% 0.00537
IPSILATERAL LUNG V20Gy(%) 9.2±4.1 7.9±4.2 15% 0.17484
V10Gy(%) 16.5±5.6 15±7.9 10% 0.00173
V5Gy(%) 28.6±8.7 26.6±10.9 7% 0.39838
Dmean(Gy) 6.2±1.8 5.7±2.1 8% 0.27975
CONTRA LATERAL LUNG V5Gy(%) <0.1 <0.1 - 0.34344
Structure Parameters VMAT-DIBH
LR-RT SIB
VMAT-FB
LR-RT SIB
Difference p_value
PTV D95%(%) 95.7±1.5 96.3±2.5 -1% 0.35716
Dmax/Dprescr (%) 107.2±3.4 105.5±2.0 2% 0.09113
Contra lateral Breast Dmean(Gy) 1.9±0.7 1.9±0.8 0% 0.53635
Heart V40Gy(%) <0.1 <0.1 - 0.34344
V20Gy(%) <0.5 1.4±1.2 -75% 0.02386
V10Gy(%) 1.3±1.2 2.8±2.6 -73% 0.00208
Dmean(Gy) 2.2±0.8 3.4±1.3 -43% 0.00003
IPSILATERAL LUNG V20Gy(%) 18.3±3.7 21.1±4.5 -14% 0.02050
V10Gy(%) 32.3±5.4 35±5.9 -8% 0.16687
V5Gy(%) 48.2±5.4 51.7±6.8 -7% 0.14234
Dmean(Gy) 10.5±1.5 11.8±1.7 -12% 0.00881
CONTRA LATERAL LUNG V5Gy(%) <0.2 <0.3 67% 0.34344
Structure Parameters VMAT-DIBH
LR-RT ChestW
VMAT-FB
LR-RT ChestW
Difference p_value
PTV D95%(%) 94.2±2.0 94.1±2.7 0% 0.84023
Dmax/Dprescr (%) 113.9±3.6 115.6±4.7 -1% 0.37058
Contra lateral Breast Dmean(Gy) 2.3±1.1 2.3±1.0 0% 0.94382
Heart V40Gy(%) <0.1 <0.1 - 0.34344
V20Gy(%) <0.7 1.6±1.3 -137% 0.00190
V10Gy(%) 1.7±1.4 3.8±3.3 -76% 0.00315
Dmean(Gy) 2.2±0.8 3.5±1.5 -46% 0.00041
IPSILATERAL LUNG V20Gy(%) 17.4±4.1 21±4.1 -19% 0.00173
V10Gy(%) 30.6±5.3 34.9±5.0 -13% 0.00080
V5Gy(%) 45.8±6.7 49.7±6.7 -8% 0.04298
Dmean(Gy) 9.86±1.5 11.5±1.4 -15% 0.00020
CONTRA LATERAL LUNG V5Gy(%) <0.6 <0.3 143% 0.21068
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Figure 3: Mean DVHs for OARs 
 
 
Figure 4: Correlation between the number of monitor units and the time per arc in DIBH plans 
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VMAT-DIBH 
Displacements 
Longitudinal 
(cm) 
Lateral 
(cm) 
Vertical 
(cm) 
L-RT 0.26 ± 0.16 0.15 ± 0.11 0.17 ± 0.13 
LR-RT SIB 0.26 ± 0.25 0.27 ± 0.25 0.33 ± 0.23 
LR-RT ChestW 0.20 ± 0.16 0.21 ± 0.09 0.17 ± 0.12 
Table 3: Mean displacements for treatments in DIBH with their standard deviation. 
 
Discussion 
DIBH is a well established efficient technique permitting to spare the heart from irradiation dose during left-breast 
radiotherapy. The DIBH technique has been developed using devoted gating respiratory systems (GRS) [31-32], and a 
reduction of the dose delivered to the heart has been documented. It has been also developed without a dedicated 
GRS during conventional 3D- breast RT [26]. The introduction of intensity modulated RT (IMRT) in breast cancer RT 
has shown advantages in terms of dose homogeneity and decrease in acute toxicities [33]. VMAT represents an IMRT 
technique that has recently been shown to offer dosimetric advantages in breast RT [11]. The association of DIBH-
VMAT with a dedicated GRS has been previously reported [31]. Several studies [34-36] have demonstrated that using 
partial arcs is more effective in reducing low doses at the contra lateral OARs. In this context, the VMAT technique 
can offer several advantages compared to 3DCRT. The feasibility of fast VMAT arc delivery using the TPS Eclipse 
(Varian) has also been previously studied [37]. To the best of our knowledge, no study has reported so far an 
association of VMAT and DIBH without the use of a respiratory gating system.  
Nevertheless in our study, in the case of LR-RTChestW, the dose to the contralateral breast was slightly increased by 
using DIBH compared to FB, although it still remained below the pre-established dose constraints. Chestwall 
irradiation is known to be challenging, due to the postoperative anatomy, which makes it more difficult to avoid the 
contralateral breast. 
We aimed to evaluate a technique combining the advantages of DIBH (sparing the heart) and VMAT planification 
(precise and homogeneous dose at PTV) without the use of a dedicated equipment. We obtained reduced heart and 
ipsilateral lung doses with this technique that are comparable to those reported in the literature with a dedicated 
GRS system [22;24;29;31]. Of note, in our study, the ipsilateral lung dose reduction was only observed for LR-RT. 
These dosimetric advantages are anticipated to correlate to clinical benefits, given the well established doses of 
cardio-toxicity [7,8] and lung toxicity [7]. 
The technique we hereby describe was easy to implement and required no dedicated equipment. The reproducibility 
of the breath hold was very high, as pointed out by the minimal displacements during treatment delivery, although a 
limitation of this technique remains the fact that no documentation of the DIBH treatment could be recorded. An 
advantage of a dedicated GRS system is the documentation of the delivery of the treatment with DIBH. A further 
implementation for this technique would be:  real-time imaging with the portal imager during the actual treatment 
delivery, or alternatively, a record of the video for each patient to document proper delivery. 
Another limitation for the implementation of this technique is that it is patient- and operator- dependent and 
therefore relies on a strict clinical protocol. The patient should integrate clear instructions from the physician and 
the RTT during CT simulation. DIBH-VMAT became then technically feasible to implement, as well as cost-effective, 
given that only 2 video cameras were needed as extra equipment.  
Patient's positioning was a key step in the procedure of DIBH-VMAT delivery without any GRS. A daily CBCT 
positioning imaging was necessary before each treatment to provide accuracy in irradiation delivery. After the 
registration and corrections applied, the whole treatment should be delivered within the 3mm tolerance, which 
implied an active, continuous monitoring of the video camera by the operating RTT, throughout the beam delivery. 
Lasers set on the skin marks were very reliable. Still the RTTs must remain active, and switch off the beam, if 
necessary. Therefore, a dedicated training was a prerequisite for the implementation of the technique. 
Overall, this technique has been robustly implemented in our Department with more than 400 patients treated 
todate. Its dosimetric advantages support its use in clinical practice despite the limitations in its implementation and 
documentations and make it an interesting options for centers not disposing of dedicated GRS equipments.  
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Conclusions 
A technique combining DIBH-VMAT has been successfully implemented in our Institution, without a dedicated 
breath hold equipment. The delivery of the treatment was achieved in a reasonably short time. An adequate PTV 
coverage was obtained. The mean heart dose was significantly reduced, without any increase of the dose to the 
ipsilateral lung, while appropriately sparing the contralateral OARs. Sparing the heart to reduce risk of late radiation-
induced toxicity is pivotal, especially for a population of patients with a long anticipated survival. We believe that 
this technique could be an interesting option for institutions not disposing of dedicated breath hold equipments.  
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